EVALUATION OF AN INNOVATIVE THERAPEUTIC TO PREVENT AND/OR DELAY THE PROGRESSION OF ALI/ARDS IN A NON-HUMAN PRIMATE MODEL
$475,391FY2022Defense Health AgencyDOD
Xequel Bio, Inc., Mt. Pleasant SC
Investigators
View source on USAspending →EVALUATION OF AN INNOVATIVE THERAPEUTIC TO PREVENT AND/OR DELAY THE PROGRESSION OF ALI/ARDS IN A NON-HUMAN PRIMATE MODEL · GrantIndex